James G. Fujimoto, who is the Elihu Thomson Professor of Electrical Engineering at the Massachusetts Institute of Technology (M.I.T.), has received the 2016 EAS New York Section of the Society for Applied Spectroscopy Gold Medal Award.
James G. Fujimoto, who is the Elihu Thomson Professor of Electrical Engineering at the Massachusetts Institute of Technology (M.I.T.), has received the 2016 EAS New York Section of the Society for Applied Spectroscopy Gold Medal Award. The award was presented to Fujimoto at a technical symposium at the 2016 EAS conference in Somerset, New Jersey, on November 14.
Fujimoto’s research interests are in femtosecond laser technology and biomedical optical imaging. He is the founder of two companies, Advanced Ophthalmic Devices (acquired by Carl Zeiss) and Light Lab Imaging, Inc. (acquired by Goodman, Ltd., and St. Jude Medical). His group and collaborators invented and developed optical coherence tomography (OCT) and were the first to develop OCT in clinical ophthalmology at the New England Eye Center. As an educator, he has trained leading researchers in photonics and biophotonics.
Fujimoto received his bachelor’s, master’s, and doctorate degrees from M.I.T. He received the Discover Magazine Award for Technological Innovation in medical diagnostics, the Rank Prize in Optoelectronics, the Zeiss Research Award, and the Champalimaud Vision Prize.
Fujimoto is a member of the National Academy of Engineering, the American Academy of Arts and Sciences, and the National Academy of Sciences. He is also a Fellow of the OSA, APS, and IEEE.
An Interview with AES Mid-Career Award Recipient Jason Dwyer
July 25th 2024Jason Dwyer of the University of Rhode Island has been named the recipient of the American Electrophoresis Society’s Mid-Career Award, which honors exceptional contributions to the field of electrophoresis, microfluidics, and related areas by an individual who is currently in the middle of their career.
Glucose's Impact on Brain Cancer Cells Unveiled Through Raman Imaging
July 25th 2024Researchers have used Raman spectroscopy and chemometric methods to reveal how glucose affects normal and cancerous brain cell metabolism. Their findings highlight specific biomarkers that can distinguish metabolic changes, potentially aiding in cancer research and treatment.